The VEGF receptor, neuropilin-1, represents a promising novel target for chronic lymphocytic leukemia patients.
Piechnik A, Dmoszynska A, Omiotek M, Mlak R, Kowal M, Stilgenbauer S, Bullinger L, Giannopoulos K. The VEGF receptor, neuropilin-1, represents a promising novel target for chronic lymphocytic leukemia patients. Int J Cancer. 2013 Sep 15; 133(6):1489-96.